RedHill Biopharma (RDHL) said Monday it has been awarded approximately $8 million, including nearly $1.5 million in interest, by the New York Supreme Court in a legal case against Kukbo.
The court ruled that Kukbo failed to make payments to RedHill Biopharma according to their agreements on Oct. 25, 2021, and Mar. 14, 2022, the company said.
Kukbo has the right to appeal the court's decision, it added.
RDHL shares were up over 4% in recent trading.
Price: 8.52, Change: +0.34, Percent Change: +4.16
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments